NCT05823480 2024-09-19Magrolimab in Combination with Azacitidine After Allogeneic HCTin Treating Patients with High-Risk AML or MDSCity of Hope Medical CenterPhase 1 Withdrawn
NCT06210750 2024-05-17Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL)National Cancer Institute (NCI)Phase 2 Withdrawn